Multiple Myeloma
Showing NaN - NaN of 56
Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))
Completed
- Lymphoma
- Multiple Myeloma
- Lenalidomide
- +4 more
-
Muscle Shoals, Alabama
- +215 more
May 5, 2022
Multiple Myeloma, Deletion 17P Syndrome Trial in Italy (Daratumumab, Pomalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Deletion 17P Syndrome
- Daratumumab
- +2 more
-
Ancona, Italy
- +14 more
Mar 24, 2022
Multiple Myeloma Trial in Italy, Netherlands (CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE)
Active, not recruiting
- Multiple Myeloma
- CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE
-
Rionero In Vulture, PZ, Italy
- +12 more
Mar 24, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- Pom/dex (Pomalidomide plus low dose Dexamethasone)
-
Tucson, Arizona
- +163 more
Feb 25, 2022
Presentation, Treatment Patterns, and Outcomes in Multiple
Completed
- Multiple Myeloma
- No Intervention
-
Little Rock, Arkansas
- +136 more
Feb 15, 2022
Multiple Myeloma Trial in Worldwide (Teclistamab, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
-
Melbourne, Australia
- +13 more
Feb 7, 2022
Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)
Completed
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- Dexamethasone
-
Whittier, California
- +19 more
Feb 2, 2022
Multiple Myeloma Trial in Worldwide (Pomalidomide, Dexamethasone)
Completed
- Multiple Myeloma
-
Graz, Austria
- +111 more
Dec 10, 2021
Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Selinexor
- +2 more
-
Plantation, Florida
- +156 more
Nov 23, 2021
Multiple Myeloma Trial in Italy (Observation)
Recruiting
- Multiple Myeloma
- Observation
-
Ancona, Italy
- +9 more
Aug 6, 2021
Multiple Myeloma Trial in Worldwide (Bortezomib, Melphalan, Prednisone (VMP), 1 or 2 cycle(s) HDM (High Dose Melphalan), 2
Active, not recruiting
- Multiple Myeloma
- Bortezomib, Melphalan, Prednisone (VMP)
- +2 more
-
Brisbane, Australia
- +207 more
Mar 22, 2021
Multiple Myeloma, Extramedullary Plasmacytoma Trial in Greece, Italy, Turkey (Daratumumab, Bortezomib, Cyclophosphamide)
Recruiting
- Multiple Myeloma
- Extramedullary Plasmacytoma
- Daratumumab
- +3 more
-
Athens, Greece
- +7 more
Feb 4, 2021
Multiple Myeloma Trial in Worldwide (Lenalidomide and low-dose dexamethasone, Lenalidomide plus low-dose dexamethasone given for
Completed
- Multiple Myeloma
- Lenalidomide and low-dose dexamethasone
- +2 more
-
Birmingham, Alabama
- +287 more
Nov 7, 2019
Multiple Myeloma Trial in Worldwide (Carfilzomib, Bortezomib, Dexamethasone)
Multiple Myeloma Trial in Worldwide (pomalidomide, Dexamethasone)
Completed
- Multiple Myeloma
-
Rochester, Minnesota
- +93 more
Sep 25, 2018